OmniAb (OABI) Cash from Investing Activities (2021 - 2026)

OmniAb's (OABI) quarterly Cash from Investing Activities came in at $8.4 million in Q1 2026, up 1060.82% year-on-year from $726727.6 in Q1 2025, and up 211.18% on a QoQ basis from $2.7 million in Q4 2025.

OmniAb (OABI) Cash from Investing Activities (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Cash from Investing Activities data on file, last reported at $8.4 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 1060.82% year-over-year to $8.4 million in Q1 2026; TTM through Mar 2026 was $15.8 million, a 7.55% decrease from a year earlier, with the FY2025 full-year figure at $6.5 million, down 82.93% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $8.4 million, up from $2.7 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for OABI reached as high as $19.9 million in Q1 2024 and fell as low as -$60.2 million in Q4 2022.
  • Historically, Cash from Investing Activities has averaged -$2.3 million across 5 years, with a median of $2.7 million in 2025.
  • Across the five-year window, Cash from Investing Activities sank 841.78% in 2023 and jumped 1060.82% in 2026, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$60.2 million in 2022, then soared by 107.86% to $4.7 million in 2023, then plunged by 91.86% to $385000.0 in 2024, then soared by 604.16% to $2.7 million in 2025, then soared by 211.18% to $8.4 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $8.4 million in Q1 2026, $2.7 million in Q4 2025, and -$7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 OmniAb 260.98 Mn 211.91 Mn 14.41 Mn 8.44 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.44 Mn
Mar 31, 2026 8.44 Mn
Dec 31, 2025 2.71 Mn
Dec 31, 2025 2.71 Mn
Sep 30, 2025 -7.67 Mn
Sep 30, 2025 -7.67 Mn
Jun 30, 2025 12.30 Mn
Jun 30, 2025 12.30 Mn
Mar 31, 2025 -878,000.00
Mar 31, 2025 -878,000.00
Dec 31, 2024 385,000.00
Dec 31, 2024 385,000.00
Sep 30, 2024 4.45 Mn
Sep 30, 2024 4.45 Mn
Jun 30, 2024 13.11 Mn
Jun 30, 2024 13.11 Mn
Mar 31, 2024 19.94 Mn
Mar 31, 2024 19.94 Mn
Dec 31, 2023 4.73 Mn
Dec 31, 2023 4.73 Mn